LYVE1 Antibody / XLKD1

NSJ Bioreagents
Product Code: NSJ-F54384
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-F54384-0.08ML0.08 ml£260.00
Quantity:
NSJ-F54384-0.4ML0.4 ml£502.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: Rabbit Ig
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
Applications:
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Western Blot (WB)
Storage:
Aliquot the LYVE1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Images

1 / 5
Western blot testing of human liver lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
2 / 5
Western blot testing of human Y79 cell lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
3 / 5
Western blot testing of mouse liver lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
4 / 5
Western blot testing of 1) non-transfected and 2) transfected 293 cell lysate with LYVE1 antibody.
5 / 5
IHC testing of FFPE human breast cancer tissue with LYVE1 antibody. HIER: steam section in pH6 citrate buffer for 20 min and allow to cool prior to staining.

Western blot testing of human liver lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
Western blot testing of human Y79 cell lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
Western blot testing of mouse liver lysate with LYVE1 antibody. Expected molecular weight: 35-65 kDa depending on glycosylation level.
Western blot testing of 1) non-transfected and 2) transfected 293 cell lysate with LYVE1 antibody.
IHC testing of FFPE human breast cancer tissue with LYVE1 antibody. HIER: steam section in pH6 citrate buffer for 20 min and allow to cool prior to staining.

Further Information

Application Details :
Western blot: 1:500-1:2000,Immunohistochemistry (FFPE): 1:25
Application Note:
The stated application concentrations are suggested starting points. Titration of the LYVE1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Description:
One of the key groups of molecules regulating leukocyte and tumour cell migration is the glycosaminoglycan hyaluronan (HA). In inflammation, the exit of leukocytes across vascular endothelium to the underlying tissues involves interactions with cell surface lectin-like receptors on the leukocytes that bind HA on the lumenal surface of the endothelium. During normal tissue homeostasis and after tissue injury, HA is mobilized from these sites through lymphatic vessels to the lymph nodes where it is degraded before entering the circulation for rapid uptake by the liver. Lymphatic vessel endothelial hyaluronan receptor (LYVE)-1 is a major receptor for HA on the lymph vessel wall. LYVE-1 is expressed primarily on lymphatic vessel endothelium and is likely to be involved in regulating the traffic of leucocytes and tumour cells to lymph nodes.
Format :
Purified
Formulation :
In 1X PBS, pH 7.4, with 0.09% sodium azide
Immunogen:
A portion of amino acids 46-77 from the human protein was used as the immunogen for the LYVE1 antibody.
Limitation:
This LYVE1 antibody is available for research use only.
Purity:
SAS precipitation
Species Reactivity :
Human, Mouse
Uniprot #:
Q9Y5Y7